NCT00633126

Pharmacokinetics of Ceftaroline in Subjects 12 to 17 Years of Age

Pharmacokinetics of a Single Dose of Ceftaroline in Subjects 12 to 17 Years of Age Receiving Antibiotic Therapy

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 9 (actual)
• Sponsor: Forest Laboratories · Industry
• Sex: All
• Age: 12 Years – 17 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine the pharmacokinetics of ceftaroline in pediatric subjects

Detailed description

The purpose of this study is to determine the pharmacokinetics profile of ceftaroline in pediatric subjects

Conditions

• Infection

Interventions

Type	Name	Description
DRUG	ceftaroline	Single parenteral infusion at a dose of 8 mg/kg for subjects weighing less than 75 kg or at a dose of 600 mg for subjects weighing greater than or equal to 75 kg infused over 60 minutes.

Timeline

• Start date: 2008-03-01
• Primary completion: 2009-02-01
• Completion: 2009-02-01
• First posted: 2008-03-11
• Last updated: 2017-03-14
• Results posted: 2013-02-12

Locations

4 sites across 1 country: United States